Bevacizumab vs Ranibizumab for Age-Related Macular Degeneration: Early Results of a Prospective Double-Masked, Randomized Clinical Trial

被引：6
|
作者：
Donahue, Sean P.
Recchia, Franco
Sternberg, Paul, Jr.
机构：
来源：
AMERICAN JOURNAL OF OPHTHALMOLOGY | 2010年 / 150卷 / 02期
关键词：
D O I：
10.1016/j.ajo.2010.04.006
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
引用
收藏
页码：287 / 287
页数：1
相关论文
共 50 条
  • [21] Bevacizumab vs ranibizumab for neovascular age-related macular degeneration in Chinese patients
    Li, Jun
    Zhang, Han
    Sun, Peng
    Gu, Feng
    Liu, Zhe-Li
    INTERNATIONAL JOURNAL OF OPHTHALMOLOGY, 2013, 6 (02) : 169 - 173
  • [22] PROSPECTIVE RANDOMIZED CONTROLLED TRIAL OF COMBINATION RANIBIZUMAB AND KETOROLAC FOR WET AGE-RELATED MACULAR DEGENERATION
    Russo, Andrea
    Costagliola, Ciro
    Delcassi, Luisa
    Romano, Mario
    Semeraro, Francesco
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [23] Prospective Randomized Controlled Trial of Combination Ranibizumab and Indomethacin for Neovascular Age-Related Macular Degeneration
    Russo, Andrea
    Gambicorti, Elena
    Morescalchi, Francesco
    Semeraro, Francesco
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2018, 59 (09)
  • [24] Ranibizumab and Bevacizumab for Treatment of Neovascular Age-Related Macular Degeneration
    Martin, Daniel F.
    Maguire, Maureen G.
    Fine, Stuart L.
    Ying, Gui-shuang
    Jaffe, Glenn J.
    Grunwald, Juan E.
    Toth, Cynthia
    Redford, Maryann
    Ferris, Frederick L., III
    OPHTHALMOLOGY, 2012, 119 (07) : 1388 - 1398
  • [25] Improvement of Retinal Function in Early Age-Related Macular Degeneration After Lutein and Zeaxanthin Supplementation: A Randomized, Double-Masked, Placebo-Controlled Trial
    Ma, Le
    Dou, Hong-Liang
    Huang, Yang-Mu
    Lu, Xin-Rong
    Xu, Xian-Rong
    Qian, Fang
    Zou, Zhi-Yong
    Pang, Hong-Lei
    Dong, Peng-Cheng
    Xiao, Xin
    Wang, Xun
    Sun, Ting-Ting
    Lin, Xiao-Ming
    AMERICAN JOURNAL OF OPHTHALMOLOGY, 2012, 154 (04) : 625 - 634
  • [26] Comparison trial reveals bevacizumab to be as effective as ranibizumab for treating age-related macular degeneration
    不详
    EXPERT REVIEW OF OPHTHALMOLOGY, 2011, 6 (03) : 279 - 279
  • [27] External beam irradiation of subfoveal choroidal neovascularization complicating age related macular degeneration: 1 year results of a prospective, double-masked, randomized pilot clinical trial.
    Marcus, DM
    Sheils, WC
    McIntosh, SB
    Johnson, MH
    Leibach, DB
    Alexander, J
    Maguire, AM
    Samy, CN
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2000, 41 (04) : S179 - S179
  • [28] Clinical safety of ranibizumab in age-related macular degeneration
    Schmidt-Erfurth, Ursula
    EXPERT OPINION ON DRUG SAFETY, 2010, 9 (01) : 149 - 165
  • [29] Thalidomide polyneuropathy: A prospective double-masked placebo-controlled study in an elderly population with age-related macular degeneration
    Khella, SL
    Souayah, N
    NEUROLOGY, 2001, 56 (08) : A208 - A209
  • [30] Ranibizumab versus Bevacizumab to Treat Neovascular Age-related Macular Degeneration
    Chakravarthy, Usha
    Harding, Simon P.
    Rogers, Chris A.
    Downes, Susan M.
    Lotery, Andrew J.
    Wordsworth, Sarah
    Reeves, Barnaby C.
    OPHTHALMOLOGY, 2012, 119 (07)
12345